These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 30547230)

  • 1. Type 2 diabetes mellitus, brain atrophy and cognitive decline in older people: a longitudinal study.
    Callisaya ML; Beare R; Moran C; Phan T; Wang W; Srikanth VK
    Diabetologia; 2019 Mar; 62(3):448-458. PubMed ID: 30547230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes: The Sydney Memory and Ageing Study.
    Samaras K; Makkar S; Crawford JD; Kochan NA; Wen W; Draper B; Trollor JN; Brodaty H; Sachdev PS
    Diabetes Care; 2020 Nov; 43(11):2691-2701. PubMed ID: 32967921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does left ventricular hypertrophy affect cognition and brain structural integrity in type 2 diabetes? Study design and rationale of the Diabetes and Dementia (D2) study.
    Patel SK; Restrepo C; Werden E; Churilov L; Ekinci EI; Srivastava PM; Ramchand J; Wai B; Chambers B; O'Callaghan CJ; Darby D; Hachinski V; Cumming T; Donnan G; Burrell LM; Brodtmann A
    BMC Endocr Disord; 2017 Apr; 17(1):24. PubMed ID: 28388897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observational Study of Brain Atrophy and Cognitive Decline Comparing a Sample of Community-Dwelling People Taking Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Over Time.
    Moran C; Xie K; Poh S; Chew S; Beare R; Wang W; Callisaya M; Srikanth V
    J Alzheimers Dis; 2019; 68(4):1479-1488. PubMed ID: 30909218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain imaging correlates of mild cognitive impairment and early dementia in patients with type 2 diabetes mellitus.
    Groeneveld O; Reijmer Y; Heinen R; Kuijf H; Koekkoek P; Janssen J; Rutten G; Kappelle L; Biessels G;
    Nutr Metab Cardiovasc Dis; 2018 Dec; 28(12):1253-1260. PubMed ID: 30355471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 2 diabetes mellitus, brain atrophy, and cognitive decline.
    Moran C; Beare R; Wang W; Callisaya M; Srikanth V;
    Neurology; 2019 Feb; 92(8):e823-e830. PubMed ID: 30674592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 2 Diabetes Mellitus and Impaired Renal Function Are Associated With Brain Alterations and Poststroke Cognitive Decline.
    Ben Assayag E; Eldor R; Korczyn AD; Kliper E; Shenhar-Tsarfaty S; Tene O; Molad J; Shapira I; Berliner S; Volfson V; Shopin L; Strauss Y; Hallevi H; Bornstein NM; Auriel E
    Stroke; 2017 Sep; 48(9):2368-2374. PubMed ID: 28801477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of long-term hyperglycaemia and insulin resistance with brain atrophy and cognitive decline: A longitudinal cohort study.
    Yu JH; Kim REY; Park SY; Lee DY; Cho HJ; Kim NH; Yoo HJ; Seo JA; Kim SG; Choi KM; Baik SH; Shin C; Kim NH
    Diabetes Obes Metab; 2023 Apr; 25(4):1091-1100. PubMed ID: 36564910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe hypoglycaemia, mild cognitive impairment, dementia and brain volumes in older adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) cohort study.
    Lee AK; Rawlings AM; Lee CJ; Gross AL; Huang ES; Sharrett AR; Coresh J; Selvin E
    Diabetologia; 2018 Sep; 61(9):1956-1965. PubMed ID: 29961106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mind Diet Adherence and Cognitive Performance in the Framingham Heart Study.
    Melo van Lent D; O'Donnell A; Beiser AS; Vasan RS; DeCarli CS; Scarmeas N; Wagner M; Jacques PF; Seshadri S; Himali JJ; Pase MP
    J Alzheimers Dis; 2021; 82(2):827-839. PubMed ID: 34092629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functions.
    Ossenkoppele R; van der Flier WM; Verfaillie SC; Vrenken H; Versteeg A; van Schijndel RA; Sikkes SA; Twisk J; Adriaanse SM; Zwan MD; Boellaard R; Windhorst AD; Barkhof F; Scheltens P; Lammertsma AA; van Berckel BN
    Neurology; 2014 May; 82(20):1768-75. PubMed ID: 24748672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive performance in midlife type 2 diabetes: results from the ENBIND study.
    Dyer AH; McKenna L; Gamage G; Bourke NM; Killane I; Widdowson M; Woods CP; Gibney J; Reilly R; O'Neill D; Kennelly SP
    Diabet Med; 2021 Jun; 38(6):e14412. PubMed ID: 32997841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of glucose disorders on cognition and brain volumes in the elderly: the Sydney Memory and Ageing Study.
    Samaras K; Lutgers HL; Kochan NA; Crawford JD; Campbell LV; Wen W; Slavin MJ; Baune BT; Lipnicki DM; Brodaty H; Trollor JN; Sachdev PS
    Age (Dordr); 2014 Apr; 36(2):977-93. PubMed ID: 24402401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults.
    Bilgel M; An Y; Helphrey J; Elkins W; Gomez G; Wong DF; Davatzikos C; Ferrucci L; Resnick SM
    Brain; 2018 Aug; 141(8):2475-2485. PubMed ID: 29901697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippocampal atrophy, asymmetry, and cognition in type 2 diabetes mellitus.
    Milne NT; Bucks RS; Davis WA; Davis TME; Pierson R; Starkstein SE; Bruce DG
    Brain Behav; 2018 Jan; 8(1):e00741. PubMed ID: 29568674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrophy in Distributed Networks Predicts Cognition in Alzheimer's Disease and Type 2 Diabetes.
    Buss SS; Padmanabhan J; Saxena S; Pascual-Leone A; Fried PJ
    J Alzheimers Dis; 2018; 65(4):1301-1312. PubMed ID: 30149455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid β Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia.
    Zhao Y; Tudorascu DL; Lopez OL; Cohen AD; Mathis CA; Aizenstein HJ; Price JC; Kuller LH; Kamboh MI; DeKosky ST; Klunk WE; Snitz BE
    JAMA Neurol; 2018 Jan; 75(1):88-96. PubMed ID: 29114732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults.
    Risacher SL; McDonald BC; Tallman EF; West JD; Farlow MR; Unverzagt FW; Gao S; Boustani M; Crane PK; Petersen RC; Jack CR; Jagust WJ; Aisen PS; Weiner MW; Saykin AJ;
    JAMA Neurol; 2016 Jun; 73(6):721-32. PubMed ID: 27088965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral haemodynamics, cognition and brain volumes in patients with type 2 diabetes.
    Brundel M; van den Berg E; Reijmer YD; de Bresser J; Kappelle LJ; Biessels GJ;
    J Diabetes Complications; 2012; 26(3):205-9. PubMed ID: 22520398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.